Cardiac Science and Concentra Health Services to Co-Market AEDs and Training Programs to Corporations
08 November 2004 - 5:30PM
PR Newswire (US)
Cardiac Science and Concentra Health Services to Co-Market AEDs and
Training Programs to Corporations IRVINE, Calif., and ADDISON,
Texas, Nov. 8 /PRNewswire-FirstCall/ -- Cardiac Science, Inc.
(NASDAQ:DFIB), a leading manufacturer of life-saving automatic
public-access defibrillators (AEDs), and Concentra Inc., a
comprehensive healthcare services provider serving industry and
group health care markets, announced today a strategic distribution
relationship whereby the sales organizations of both companies will
jointly market Cardiac Science AEDs, associated AED/CPR training
and program management services to Concentra customers. Concentra
Health Services customer base includes more than 120,000 U.S.
corporations. "Our 300-member sales organization, comprised of
health services managers, account managers and national account
managers, field inquiries from our customers about deploying AEDs
in the workplace," said Keith Newton, President of Concentra Health
Services. "This partnership allows us to offer the best in class
Powerheart(R) AED as well as training and program management
services to our customers. We view workplace defibrillation
programs as highly complementary to our core employee wellness
services." Raymond W. Cohen, Chairman and CEO of Cardiac Science,
commented on the partnership by stating, "Corporate executives are
fast becoming aware that the availability of AEDs in the workplace
is not only an important employee benefit, but is also a great
means of risk mitigation for the company." "As a leader in
workplace healthcare services, Concentra has an established reach
into thousands of U.S. corporations, which we believe is one of the
most under penetrated AED market segments and where Cardiac Science
has the ideal product and service offering," continued Cohen.
"Concentra has a unique relationship with its customers and we
anticipate this will open up a new marketing channel for AEDs in
the workplace. We look forward to working with the Concentra sales
team as partners in expanding our reach and in helping corporations
establish safe work environments." About Concentra Inc. Concentra
Inc. is the comprehensive outsourcing solution for containing
healthcare and disability costs. Serving the occupational, auto and
group healthcare markets, Concentra provides employers, insurers
and payors with a variety of integrated healthcare services. These
services include employment-related injury and occupational
healthcare, in-network and out-of- network medical claims review
and re-pricing, access to specialized preferred provider
organizations, first notice of loss services, case management and
other cost containment services. Concentra is a registered
trademark of Concentra Operating Corporation. All rights reserved.
http://www.concentra.com/ About Concentra Health Services, Inc.(R)
Headquartered in Addison, Texas, Concentra Health Services, Inc. is
a leading healthcare company offering a broad range of services
that provide quality patient care for work-related injuries while
containing the rising costs of occupational healthcare and workers'
compensation. The company operates over 250 occupational medical
centers, in 84 markets, and 34 states. Concentra Health Services,
Inc., is a wholly owned subsidiary of Concentra Inc. Copyright 2004
Concentra Operating Corporation. All rights reserved.
http://www.concentra.com/ About Cardiac Science Cardiac Science
develops, manufactures and markets Powerheart(R)-brand
public-access defibrillators (AEDs) and offers comprehensive
AED/CPR training and AED program management services that
facilitate successful deployments. The Company also makes the
Powerheart(R) CRM(TM), the only FDA-cleared therapeutic patient
monitor that instantly and automatically treats hospitalized
cardiac patients who suffer life-threatening heart rhythms. In
addition, its 55-person sales force in the U.S. and independent
distributors in over 40 countries, Cardiac Science also
manufactures its AED products on a private label basis for other
leading medical companies such as Nihon Kohden (Japan), Quinton
Cardiology Systems and GE Healthcare. For more information, please
visit http://www.cardiacscience.com/. This news release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. In addition, from time to
time the company, or its representatives, have made or may make
forward looking statements orally or in writing. The words
"estimate," "potential," "intended," "expect," "anticipate,"
"believe," and similar expressions or words are intended to
identify forward looking statements. Such forward-looking
statements include, but are not limited to the achievement of
future revenue growth based on the co-marketing alliance with
Concentra. Cardiac Science cautions that these statements are
subject to substantial risks and uncertainties and are qualified by
important factors that could cause actual results to differ
materially from those reflected by the forward-looking statements
and should not be relied upon by investors when making an
investment decision. Information on these and other factors is
detailed in the Company's Form 10-K for the year ending December
31, 2003, subsequent quarterly filings, and other documents filed
by the Company with the Securities and Exchange Commission. For
further information please contact: investors, Matt Clawson, , or
media, Len Hall, , both of Allen & Caron Inc, +1-949-474-4300,
for Cardiac Science, Inc.; or Michael Gioffredi, Chief Marketing
Officer of Cardiac Science, Inc., +1-949-797-3800, . DATASOURCE:
Cardiac Science, Inc.; Concentra Inc. CONTACT: investors, Matt
Clawson, , or media, Len Hall, , both of Allen & Caron Inc,
+1-949-474-4300, for Cardiac Science, Inc.; or Michael Gioffredi,
Chief Marketing Officer of Cardiac Science, Inc., +1-949-797-3800,
Web site: http://www.concentra.com/ Web site:
http://www.cardiacscience.com/
Copyright
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jul 2023 to Jul 2024